RECRUITING

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Texas Southwestern (UTSW).

Official Title

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Quick Facts

Study Start:2006-12
Study Completion:2025-01-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01510067

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subjects who meet the criteria for having CLE, using the Gilliam classifications, and/or a diagnosis of systemic lupus erythematosus (SLE), using the American Rheumatism Association/American College of Rheumatology criteria. Subjects must be 18 years or older.
  1. * All subjects who do not meet the criteria for having CLE. Subjects who meet the criteria for CLE but who are not yet 18 years old

Contacts and Locations

Study Contact

Victoria P Werth, MD
CONTACT
215-615-2940
werth@pennmedicine.upenn.edu
Joyce Okawa, R.N
CONTACT
215-615-2940
Joyce.Okawa@pennmedicine.upenn.edu

Principal Investigator

Victoria Werth, M.D.
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States
University of Texas Southwestern
Dallas, Texas, 75390
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

  • Victoria Werth, M.D., PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2006-12
Study Completion Date2025-01-02

Study Record Updates

Study Start Date2006-12
Study Completion Date2025-01-02

Terms related to this study

Keywords Provided by Researchers

  • CLE
  • Lupus
  • Lupus Erythematosus

Additional Relevant MeSH Terms

  • Cutaneous Lupus Erythematosus (CLE)